Publication | Closed Access
GS-12-Ascending dose cohort study of inarigivir - A novel RIG I agonist in chronic HBV patients: Final results of the ACHIEVE trial
31
Citations
0
References
2019
Year
Viral PersistenceImmunologyAntiviral Drug DevelopmentHepatitisVirologyAchieve TrialChronic Hbv PatientsAntiviral TherapyPharmacotherapyChronic Viral InfectionAntiviral DrugNovel RigMedicine
No additional data available for this publication yet. Check back later!